Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiphospholipid antibody syndrome: current concepts

N Goel1

  • 1Department of Internal Medicine, University of Texas Medical Branch at Galveston, USA.

Hospital Practice (1995)
|March 4, 1998
PubMed
Summary

Antiphospholipid antibody syndrome (APS) causes hypercoagulability and thrombotic events. Evaluation for APS is crucial in unexplained thrombosis, as it can be primary or secondary to other autoimmune conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bull's head sign in chronic reactive arthritis.

QJM : monthly journal of the Association of Physicians·2024
Same author

MDA5 dermatomyositis-skin says it all.

QJM : monthly journal of the Association of Physicians·2024
Same author

'Tortoise shell appearance' of parotid gland in advanced Sjogren's syndrome.

QJM : monthly journal of the Association of Physicians·2024
Same author

Frosted branch angiitis in Behcet disease.

QJM : monthly journal of the Association of Physicians·2024
Same author

Real-world implementation of non-endoscopic triage testing for Barrett's oesophagus during COVID-19.

QJM : monthly journal of the Association of Physicians·2023
Same author

Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018.

Canadian journal of surgery. Journal canadien de chirurgie·2022

Area of Science:

  • Rheumatology
  • Hematology
  • Immunology

Background:

  • Antiphospholipid antibody syndrome (APS) is a recognized autoimmune disorder.
  • It is characterized by recurrent thrombotic events and pregnancy-related complications.
  • APS is associated with a prothrombotic state, or hypercoagulability.

Purpose of the Study:

  • To highlight the importance of evaluating unexplained thrombotic events for APS.
  • To discuss the primary and secondary forms of APS.
  • To address the ongoing research into thrombosis mechanisms and treatment controversies in APS.

Main Methods:

  • This abstract is based on a review of current understanding of APS.
  • It synthesizes information on clinical manifestations and diagnostic considerations.
  • It discusses the underlying pathophysiology and therapeutic challenges.

Main Results:

  • APS is a significant cause of hypercoagulability.
  • Clinical manifestations are diverse, including thrombotic events.
  • The disorder can be idiopathic (primary) or associated with other autoimmune diseases (secondary).

Conclusions:

  • Patients with unexplained thrombosis require evaluation for APS.
  • Further research is needed to fully elucidate the mechanisms of thrombosis in APS.
  • Optimal therapeutic strategies for APS are still under investigation and remain controversial.

Related Experiment Videos